Showing results (51-60 of 3,965) with videos related to
Sort By:
Pageof 397
Cancer Treatment Reports|January 1, 1981
Future clinical investigations with anthracycline antibiotics in relation to daunorubicinF M Muggia, R H Blum, J C WernzAnnals of Internal Medicine|August 1, 1976
5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemiaD D Von Hoff, M Slavik, F M MuggiaAnti-Cancer Drugs|January 7, 1999
Gemcitabine plus cisplatin combination given with amifostine (GAP) to heavily pretreated patients with gynecologic and peritoneal cancers: tolerance and activity in ovarian cancerT Safra, S Jeffers, J Sorich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapyJ L Speyer, U Beller, N Colombo, et al.Anticancer Research|July 1, 1988
A new look at radionuclides therapy in metastatic disease of bone (review and prospects)S I Kim, D C Chen, F M MuggiaInternational Journal of Radiation Oncology, Biology, Physics|January 1, 1984
Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologiesF M Muggia, R H Blum, J D ForemanInvestigational New Drugs|January 1, 1985
Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot studyR H Earhart, F M Muggia, F M GolombAnnals of Internal Medicine|January 1, 1978
Hormonal therapy of breast cancer: new approaches and conceptsS S Legha, H L Davis, F M MuggiaMedical and Pediatric Oncology|January 1, 1976
Overview of early and investigational chemotherapeutic agents in solid tumorsM Rozencweig, M Slavik, F M Muggia, et al.Biochemical Pharmacology|May 1, 1987
Lethal and sublethal effects of the combination of doxorubicin and the bisdioxopiperazine, (+)-1,2,-bis (3-5-dioxopiperazinyl-1-yl) propane (ICRF 187), on murine sarcoma S180 in vitroS Wadler, M D Green, R Basch, et al.Pageof 397